Safety and Feasibility of an Integrated Fabric-Type Orthosis for Gait and Balance Improvement in Geriatric Patients
Safety and Feasibility of an Integrated Fabric- Type Orthosis With Muscle-Mimicking and Proprioception-Enhancing Functions for Improving Gait and Balance in Geriatric Patients: Pilot Clinical Trial
This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: junghyun kim, prof
- Telefonnummer: 82+1088632341
- E-Mail: kiking0@naver.com
Studienorte
-
-
Jongno
-
Seoul, Jongno, Südkorea, 03080
- Rekrutierung
- Seoul National University Hospital
-
Kontakt:
- junghyun kim, prof
- Telefonnummer: 82+1059657182
- E-Mail: kiking0@naver.com
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Eligibility for participation in the study requires that all the following criteria are met:
-
Age: Participants must be 65 years of age or older.
-
Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.
-
Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:
- Muscle Strength: Handgrip strength of <28 kg for men and <18 kg for women.
- Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
- Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass <7.0 kg/m² for men and <5.7 kg/m² for women. (2)Diabetes:
- Diagnosed distal symmetric polyneuropathy.
- Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
- Kellgren-Lawrence grade ≥2.
- Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).
Exclusion Criteria:
Individuals meeting any of the following criteria will be excluded from study participation:
-
Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.
-
Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.
-
Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.
-
Independent Walking Inability: Cannot walk independently without the aid of a walking device.
-
Other Significant Diseases or Conditions:
- Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
- Orthopedic or musculoskeletal conditions severely affecting lower limb function.
- Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
- Respiratory diseases requiring regular oxygen therapy.
- Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
- Severe psychiatric disorders like schizophrenia or bipolar disorder.
-
Other Exclusionary Factors:
- Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
- Severe back pain or any other condition affecting mobility not already listed.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Integrated Fabric-Type Orthosis Evaluation
Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults. |
A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Blood Pressure From Before to After Functional Assessment
Zeitfenster: Immediately before and after the functional assessment at each study visit
|
Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions. |
Immediately before and after the functional assessment at each study visit
|
|
Change in Heart Rate From Before to After Functional Assessment
Zeitfenster: Immediately before and after the functional assessment at each study visit
|
Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions. |
Immediately before and after the functional assessment at each study visit
|
|
Change in Perceived Exertion From Before to After Functional Assessment
Zeitfenster: Immediately before and after the functional assessment at each study visit
|
Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion. |
Immediately before and after the functional assessment at each study visit
|
|
Change in Pain Intensity From Before to After Functional Assessment
Zeitfenster: Immediately before and after the functional assessment at each study visit
|
Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity. |
Immediately before and after the functional assessment at each study visit
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
6-Minute Walk Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
10-Meter Walk Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To assess gait speed and short-distance walking performance under different orthosis conditions. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
20-Meter Walk Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To assess walking speed and gait performance over a longer walking distance. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Surface Electromyography
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Static One-Leg Standing Balance Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To evaluate static balance ability by measuring the duration participants can maintain single-leg standing. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Postural Sway
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Passive Joint Position Reproduction Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Active Joint Position Reproduction Test
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error. |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Participant Satisfaction
Zeitfenster: Immediately post-brace activation (power on)
|
To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis. |
Immediately post-brace activation (power on)
|
|
Gait Speed
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Gait speed measured using the GAITRite system, reported in meters per second (m/s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Cadence
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Cadence measured using the GAITRite system, reported in steps per minute (steps/min). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Step Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Step time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Step Length
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Step length measured using the GAITRite system, reported in centimeters (cm). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Stride Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Stride time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Stride Length
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Stride length measured using the GAITRite system, reported in centimeters (cm). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Single Support Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Single support time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Double Support Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Double support time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Stance Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Stance time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
|
Swing Time
Zeitfenster: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Swing time measured using the GAITRite system, reported in seconds (s). |
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Studienleiter: hyungik shin, prof, Seoul National University Hospital
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- H-2603-077-1726
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .